"We have been able to decrease over $600mln in imports of drugs, medical equipment and raw materials in the past year," Namaki said, addressing Iranian parliamentarians in Tehran on Wednesday.
"We reduced 25% in imports of drugs and medical equipment and increased domestic production by 30% last year," he added.
Namaki underlined that his ministry has banned imports of any medicine and medical equipment which could be produced inside the country.
In relevant remarks earlier this month, Director-General of Drugs and Materials under the Iran Food and Drug Administration (IFDA) Gholam Hossein Mehr Alian announced that production of drugs and medical equipment inside the country has saved nearly $400mln in a year.
"Our foreign currency consumption decreased 20% last year by focusing on domestic capabilities and we saved $400mln last year compared with the previous year," Mehr Alian said.
He underlined Iran's reliance on indigenous power in the current year, and said efforts are focused on production of medicine inside the country as far as domestic capacities allow.
Late in September, Iranian Vice-President for Science and Technology Sorena Sattari announced that the country's experts have been able to obviate nearly all people's needs to medicine irrespective of the United States' harsh sanctions.
"Our researchers have bypassed the sanctions in all scientific fields," Sattari told FNA on Sunday.
"At present, 98% of the drugs needed by our country's people is produced inside the country and by our researchers," he added.
Sattari underscored that the US sanctions have certainly created some problems for Iran, but such problems are not too big and too major to be resolved by Iranian researchers.
A couple of days before Sattari’s announcement, Iran unveiled 6 new drugs produced by the country's experts with applications for MS, diabetes, cancer and cardiovascular patients.